1. Home
  2. SEER vs GOSS Comparison

SEER vs GOSS Comparison

Compare SEER & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$2.01

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.17

Market Cap

97.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEER
GOSS
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
97.5M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
SEER
GOSS
Price
$2.01
$0.17
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
449.8K
18.3M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
9.40
N/A
EPS
N/A
N/A
Revenue
$16,578,000.00
$48,471,000.00
Revenue This Year
$2.14
N/A
Revenue Next Year
$25.90
$201.64
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$1.55
$0.11
52 Week High
$2.41
$3.87

Technical Indicators

Market Signals
Indicator
SEER
GOSS
Relative Strength Index (RSI) 43.01 49.63
Support Level $2.00 $0.14
Resistance Level $2.09 $0.18
Average True Range (ATR) 0.06 0.02
MACD -0.02 0.00
Stochastic Oscillator 4.55 40.79

Price Performance

Historical Comparison
SEER
GOSS

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: